Found: 26
Select item for more details and to access through your institution.
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 8, p. 1327, doi. 10.1007/s00432-013-1444-y
- By:
- Publication type:
- Article
HGF/MET signalling protectsPlasmodium-infected host cells from apoptosis.
- Published in:
- Cellular Microbiology, 2005, v. 7, n. 4, p. 603, doi. 10.1111/j.1462-5822.2004.00490.x
- By:
- Publication type:
- Article
Hepatocyte growth factor and its receptor are required for malaria infection.
- Published in:
- Nature Medicine, 2003, v. 9, n. 11, p. 1363, doi. 10.1038/nm947
- By:
- Publication type:
- Article
Activation of HER family members in gastriccarcinoma cells mediates resistance to METinhibition.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 121, doi. 10.1186/1476-4598-9-121
- By:
- Publication type:
- Article
Interplay between scatter factor receptors and B plexins controls invasive growth.
- Published in:
- Oncogene, 2004, v. 23, n. 30, p. 5131, doi. 10.1038/sj.onc.1207650
- By:
- Publication type:
- Article
Molecularly Targeted Therapies for Gastric Cancer. State of the Art.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4094, doi. 10.3390/cancers13164094
- By:
- Publication type:
- Article
Patient-Derived Cancer Models.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2218, doi. 10.3390/cancers12082218
- By:
- Publication type:
- Article
BIRTH: STORIES FROM CONTEMPORARY LITERATURE AND FILM.
- Published in:
- Phenomenology & Mind, 2020, n. 19, p. 34, doi. 10.17454/pam-1903
- By:
- Publication type:
- Article
INTRODUCTION IMAGINING HUMAN REPRODUCTION.
- Published in:
- Phenomenology & Mind, 2020, n. 19, p. 12, doi. 10.17454/pam-1901
- By:
- Publication type:
- Article
Author Correction: The landscape of d16HER2 splice variant expression across HER2-positive cancers.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The Semaphorin 4D receptor controls invasive growth by coupling with Met.
- Published in:
- Nature Cell Biology, 2002, v. 4, n. 9, p. 720, doi. 10.1038/ncb843
- By:
- Publication type:
- Article
Semaphorin 4D regulates gonadotropin hormone--releasing hormone-1 neuronal migration through PlexinB1--Met complex.
- Published in:
- Journal of Cell Biology, 2008, v. 183, n. 3, p. 555, doi. 10.1083/jcb.200806160
- By:
- Publication type:
- Article
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 3, p. 473, doi. 10.1007/s10120-024-01468-8
- By:
- Publication type:
- Article
Morphology on the cloud - Virtual Campus, an integrated didactic platform for biomedical studies.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Targeted therapies in cancer and mechanisms of resistance.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
The landscape of d16HER2 splice variant expression across HER2-positive cancers.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-40310-5
- By:
- Publication type:
- Article
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 3, p. 661, doi. 10.1007/s13402-023-00769-x
- By:
- Publication type:
- Article
The importance of being CAFs (in cancer resistance to targeted therapies).
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02524-w
- By:
- Publication type:
- Article
Correction: hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02320-6
- By:
- Publication type:
- Article
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02320-6
- By:
- Publication type:
- Article
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02320-6
- By:
- Publication type:
- Article
Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction.
- Published in:
- Science Signaling, 2009, v. 2, n. 102, p. 1, doi. 10.1126/scisignal.2000643
- By:
- Publication type:
- Article
Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction.
- Published in:
- Science Signaling, 2009, v. 2, n. 100, p. 1, doi. 10.1126/scisignal.2000643
- By:
- Publication type:
- Article
Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 8, p. 1561, doi. 10.1016/j.molonc.2014.06.010
- By:
- Publication type:
- Article